GRDX
GridAI Technologies Corp.
NASDAQ: GRDX · HEALTHCARE · BIOTECHNOLOGY
$3.64
-8.35% today
Updated 2026-06-03
Market cap
$42.25M
P/E ratio
—
P/S ratio
189.83x
EPS (TTM)
$-4.14
Dividend yield
—
52W range
$1 – $7
Volume
0.1M
WallStSmart proprietary scores
22
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.5
Profitability
D5.0
Valuation
C+5/9
Piotroski F-Score
Moderate
-5.8
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.12x — low leverage
Risks
- Altman Z -5.78 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-1.79M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $36251.00 | $38208.00 |
| Net income | $-14.63M | $-15.79M | $-18.06M | $-6.55M | $-3.55M |
| EPS | — | — | — | — | $-4.14 |
| Free cash flow | $-22.34M | $-12.88M | $-9.22M | $-5.70M | $-1.79M |
| Profit margin | — | — | — | -18,078.34% | — |
Peer comparison
Smart narrative
GridAI Technologies Corp. trades at $3.64. Our Smart Value Score of 22/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of -5.78, it sits in the distress.
Frequently asked questions
What is GridAI Technologies Corp.'s stock price?
GridAI Technologies Corp. (GRDX) trades at $3.64, on a P/S of 189.8x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is GridAI Technologies Corp. overvalued?
GridAI Technologies Corp. carries a Smart Value Score of 22/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
Altman Z-Score?
GridAI Technologies Corp.'s Altman Z-Score is -5.78, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio189.83x
ROE-36.32%
Beta—
50D MA$3.09
200D MA$3.26
Shares out0.01B
Float—
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—